| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10143266 | Contemporary Clinical Trials Communications | 2018 | 25 Pages |
Abstract
The initial result demonstrated that Stevia has the potential for a significant improvement of some biochemical parameters in CKD patients. After completion of the nine (9) months clinical trial, the constructive effect of Stevia can be confirmed in this group of patients.
Keywords
ACRTotal CO2TcO2angiotensin-II receptor blockerUTPPLCARBSTVDBPSBPCCBPBSEGFRFBSSTPSteviaChronic kidney disease (CKD)chronic kidney diseaseDiabetes mellitusSerum uric acidbody mass indexBMIinorganic phosphateHypertensiondiastolic blood pressuresystolic blood pressurefasting blood sugarCa2+ channel blockerestimated glomerular filtration rateMicroalbuminCKDPCRserum total proteinPlaceboserum creatinine
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
Farhana Rizwan, Harun Ur Rashid, Saquiba Yesmine, Forhad Monjur, Tapan Kumar Chatterjee,